Broadfoot Jill Marie's Form 4 filing
aTYR PHARMA INC (ATYR) · filed Feb 6, 2023
- Accession no.
- 0001209191-23-007364
- Filed
- Feb 6, 2023
- Trade date
- Feb 3-6, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.70K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Broadfoot Jill MarieCIK 0001305178 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2023 | Common stock | MOption exerciseAcquired | +3,750 | – | – | 17,026 | Direct | |
| Feb 6, 2023 | Common stock | SSaleDisposed | −1,566 | $2.36 | −$3,695.76 | 15,460 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2023 | Common Stock | MOption exerciseDisposed | −3,750 | $0.00 | $0 | 11,250 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.